Table: RaQualia Pharma -2022 group forecast
Nov 17 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2022 Dec 31, 2022
LATEST PREVIOUS
FORECAST FORECAST
Sales 3.08 2.61
Operating 824 mln 420 mln
Recurring 909 mln 420 mln
Net 724 mln 342 mln
EPS 34.55 yen 16.34 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T